dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· March 28, 2026

Crypto News Today: Pepeto Project News While Bull Run Signals Align and Dogecoin SEC Commodity Ruling Opens the Door for What Comes Next

View original at globenewswire.com
Crypto News Today: Pepeto Project News While Bull Run Signals Align and Dogecoin SEC Commodity Ruling Opens the Door for What Comes Next Dubai, UAE, March 28, 2026 (GLOBE NEWSWIRE) -- Pepeto pushed past $8.47 million after its latest round closed ahead of schedule while the crypto news today delivered the catalysts thi…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Binance long ratio on Dogecoin flipped bullish for the first time in months

    60% confidence
  • Pepeto presale rounds close faster every week

    60% confidence
  • Binance listing is happening in the few days comings

    60% confidence
  • Analyst targets for Dogecoin in this bull run sit between $0.20 and $0.47, a respectable 2x to 5x for holders

    60% confidence
  • Pepeto organic growth is already outpacing what the team expected

    60% confidence
  • Dogecoin reached $85 billion market cap on community alone and then lost 93% because there was nothing generating demand once the attention moved on

    60% confidence
  • Active wallet addresses jumped 176% in one week

    60% confidence

Data points we hold from this source

Pepeto · funds raised8.47 USD
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Crypto News Today: Pepeto Project News While Bull Run Signals Align and Dogecoin SEC Commodity Ruling Opens the Door for What Comes Next: Source | Via News | fr.via.news